Kidney Res Clin Pract > Volume 42(6); 2023 > Article |
|
Parameter |
Albumin ≤ 3.8 g/dL (n = 21) |
Albumin > 3.8 g/dL (n = 18) |
Two-way ANCOVA |
|||||
---|---|---|---|---|---|---|---|---|
Exercise group (n = 9) | Control group (n = 12) | Exercise group (n = 9) | Control group (n = 9) | F | p | η₂ (f) | ||
Frailty (score, 0–5) | ||||||||
Baseline | 1.89 ± 0.93 | 2.91 ± 0.67 | 2.56 ± 1.42 | 2.00 ± 0.87 | G*Albumin | 5.89a | 0.02 | |
Week 12 | 1.11 ± 0.93 | 3.33 ± 0.98 | 0.78 ± 0.97 | 2.78 ± 1.09 | G*Albumin | 1.74b | 0.20 | |
Kt/V urea | ||||||||
Baseline | 1.58 ± 0.18 | 1.69 ± 0.18 | 1.70 ± 0.20 | 1.64 ± 0.22 | G*Albumin | 0.09a | 0.77 | |
Week 12 | 1.64 ± 0.25 | 1.70 ± 0.15 | 1.88 ± 0.32 | 1.56± 0.20 | G*Albumin | 5.64b | 0.02 | 0.146 (0.41) |
SPPB (0–12, score) | ||||||||
Baseline | 11.11 ± 0.93 | 9.42 ± 2.31 | 10.22 ± 1.56 | 11.00 ± 1.19 | G*Albumin | 3.87a | 0.06 | |
Week 12 | 11.11 ± 0.67 | 9.83 ± 2.41 | 11.89 ± 0.33 | 9.67 ± 2.24 | G*Albumin | 0.51b | 0.48 | |
SMM (kg) | ||||||||
Baseline | 25.57 ± 3.85 | 24.03 ± 2.90 | 25.36 ± 5.83 | 24.71 ± 5.61 | G*Albumin | 0.03a | 0.86 | |
Week 12 | 24.98 ± 4.40 | 22.59 ± 3.08 | 25.97 ± 5.49 | 23.94 ± 6.42 | G*Albumin | 0.22b | 0.64 | |
Body fat (%) | ||||||||
Baseline | 20.57 ± 7.18 | 21.51 ± 8.07 | 21.77 ± 8.86 | 23.14 ± 7.93 | G*Albumin | 0.0a | 0.85 | |
Week 12 | 22.02 ± 8.32 | 22.66 ± 8.67 | 21.62 ± 7.84 | 26.04 ± 10.11 | G*Albumin | 0.30b | 0.59 | |
LLM (kg) | ||||||||
Baseline | 16.01 ± 2.09 | 14.85 ± 3.55 | 14.82 ± 4.90 | 13.23 ± 3.45 | G*Albumin | 0.03a | 0.86 | |
Week 12 | 13.39 ± 2.34 | 12.36 ± 1.95 | 14.19 ± 3.81 | 12.73 ± 3.38 | G*Albumin | 0.34b | 0.56 | |
QoL, PCS | ||||||||
Baseline | 44.12 ± 6.29 | 43.18 ± 7.95 | 46.90 ± 6.74 | 46.28 ± 9.95 | G*Albumin | 0.22a | 0.65 | |
Week 12 | 52.62 ± 4.76 | 41.47 ± 8.60 | 50.98 ± 4.37 | 44.54 ± 8.22 | G*Albumin | 0.01b | 0.92 | |
QoL, MCS | ||||||||
Baseline | 50.60 ± 12.20 | 48.08 ± 10.29 | 50.09 ± 10.49 | 52.11 ± 7.35 | G*Albumin | 0.65a | 0.43 | |
Week 12 | 53.06 ± 6.96 | 48.92 ± 9.65 | 53.40 ± 10.43 | 49.00 ± 6.12 | G*Albumin | 0.18b | 0.67 |
Values are presented as mean ± standard deviation.
G, group (exercise vs. control); LLM, lower leg muscle mass; MCS, mental component summary; PCS, physical component summary; QoL, quality of life; SMM, skeletal muscle mass; SPPB, short physical performance battery. Kt/V: K = dialyzer’s capacity to clear urea at the blood flow rate, t = treatment time, and V = distribution volume of urea.
Parameter |
Difference |
Two-way ANCOVA |
||||||
---|---|---|---|---|---|---|---|---|
Albumin ≤ 3.8 g/dL (n = 21) |
Albumin > 3.8 g/dL (n = 18) |
|||||||
Exercise group (n = 9) | Control group (n = 12) | Exercise group (n = 9) | Control group (n = 9) | Fa | p | η₂ (f) | ||
Frailty (score, 0-5) | –0.78 ± 0.11 | 0.42 ± 0.79 | –1.78 ± 1.20 | 0.78 ± 0.83 | Group | 48.58 | <0.001 | |
Albumin | 2.14 | 0.15 | ||||||
G*Albumin | 1.74 | 0.20 | ||||||
Dialysis adequacy | 0.06 ± 0.11 | 0.01 ± 0.13 | 0.18 ± 0.27 | –0.08 ± 0.11 | Group | 6.92 | 0.01 | |
(Kt/V urea) | Albumin | 0.08 | 0.78 | |||||
G*Albumin | 3.25 | 0.08 | ||||||
SPPB (0–12, score) | 0.67 ± 1.00 | 0.42 ± 0.79 | 1.67 ± 1.41 | –1.33 ± 2.06 | Group | 15.38 | <0.001 | |
Albumin | 0.34 | 0.57 | ||||||
G*Albumin | 4.14 | 0.05 | 0.111 (0.35) | |||||
SMM (kg) | –0.59 ± 1.06 | –1.43 ± 1.14 | 0.61 ± 3.07 | –0.77 ± 1.60 | Group | 2.64 | 0.11 | |
Albumin | 2.21 | 0.15 | ||||||
G*Albumin | 0.01 | 0.93 | ||||||
Body fat (%) | 1.46 ± 3.24 | 1.15 ± 2.87 | –0.14 ± 1.86 | 2.90 ± 3.55 | Group | 1.91 | 0.18 | |
Albumin | 0.00 | 0.99 | ||||||
G*Albumin | 2.33 | 0.14 | ||||||
LLM (kg) | –2.62 ± 1.24 | –2.49 ± 2.90 | –0.63 ± 2.84 | –0.50 ± 1.26 | Group | 0.12 | 0.73 | |
Albumin | 6.46 | 0.02 | 0.164 (0.44) | |||||
G*Albumin | 0.22 | 0.64 | ||||||
PCS | 8.50 ± 6.46 | –1.71 ± 11.18 | 4.08 ± 3.81 | –1.73 ± 5.72 | Group | 3.52 | 0.07 | |
Albumin | 2.73 | 0.11 | ||||||
G*Albumin | 0.14 | 0.71 | ||||||
MCS | 2.46 ± 9.18 | 0.83 ± 10.89 | 3.31 ± 6.66 | –3.11 ± 6.95 | Group | 1.49 | 0.23 | |
Albumin | 0.27 | 0.61 | ||||||
G*Albumin | 0.29 | 0.59 |
Values are presented as mean ± standard deviation.
G, group (exercise vs. control); LLM, lower leg muscle mass; MCS, mental component summary; PCS, physical component summary; QoL, quality of life; SMM, skeletal muscle mass; SPPB, short physical performance battery. Difference = value at the 12th week – value at baseline Kt/V. K = dialyzer’s capacity to clear urea at the blood flow rate, t = treatment time, and V = distribution volume of urea.
Sun Ki Kim
https://orcid.org/0000-0001-5385-7604
Hye-Ja Park
https://orcid.org/0000-0002-8923-2611
Dong-Ho Yang
https://orcid.org/0000-0001-9404-0019